Dr. Akhil Shenoy
Transplant Psychiatry · Columbia University Irving Medical Center · NewYork-Presbyterian
Akhil Shenoy, MD, MPH is a Columbia psychiatrist whose work sits at the intersection of consultation-liaison psychiatry, transplant psychiatry, alcohol-use-disorder management, and liver-transplant evaluation. His role is especially relevant for transplant candidates because psychiatric stability, addiction treatment, adherence, coping capacity, and social support can all shape readiness for listing and long-term outcomes [1][2][3][5][6].
Shenoy Overview
Columbia Psychiatry lists Dr. Shenoy as a psychiatrist at Columbia University Irving Medical Center and identifies him as an Assistant Professor of Psychiatry. NewYork-Presbyterian lists him at CUIMC/Presbyterian Hospital and Vanderbilt Clinic on West 168th Street in Manhattan and describes his practice as psychiatry, including mood disorders, anxiety disorders, psychotherapy, and psychopharmacology [1][2].
In the transplant setting, his role is more specialized than a standard outpatient psychiatry profile. The Black Liver Health Initiative identifies him as Director of Transplant Psychiatry, and Columbia’s consultation-liaison fellowship materials place him directly within transplant-related psychiatric consultation for liver and transplantation services [3][5][6].
Why Transplant Psychiatry Matters in Liver Disease
Liver transplantation is not only a surgical and hepatology process. It is also a psychosocial and behavioral process. Patients may face depression, anxiety, insomnia, trauma, substance-use disorder, demoralization, medication nonadherence, family conflict, or uncertainty about transplant candidacy. A transplant psychiatrist helps the multidisciplinary team evaluate these issues and helps the patient move through the process more safely and realistically [5][6][8].
This is particularly important in alcohol-associated liver disease. Dr. Shenoy’s publication record includes work on relapse-risk assessment, multidisciplinary treatment of alcohol use disorder in transplant candidates and recipients, and ethical questions surrounding transplant evaluation after psychosocial rejection [6][7][8][9].
Clinical Focus and Relevance for Patients
What patients may need help with
- Depression, anxiety, panic symptoms, and adjustment reactions [1][2]
- Psychopharmacology and medication management [1][2]
- Psychotherapy and structured behavioral support [1][2]
- Assessment of transplant readiness and psychosocial barriers [5][8]
- Alcohol-use-disorder evaluation and relapse-risk reduction in transplant settings [6][7]
Why this role is valuable
- It helps patients and families understand the psychiatric side of transplant evaluation.
- It supports safer decision-making when addiction, adherence, or psychosocial instability complicate candidacy.
- It connects psychiatric care directly to hepatology and transplant surgery rather than treating each problem in isolation.
- It can improve communication, planning, and follow-through before and after transplant.
Scholarship and Academic Contribution
Dr. Shenoy’s published work reflects the modern evolution of transplant psychiatry. PubMed-indexed articles associated with him address psychosocial scoring systems for alcohol relapse after liver transplant, multidisciplinary management of alcohol use disorder in transplant candidates and recipients, and ethical questions that arise when candidates rejected for psychosocial reasons seek reevaluation elsewhere [6][7][8][9].
Columbia CUIMC’s interprofessional education materials also identify Dr. Shenoy as a presenter on the challenges of liver-transplant evaluation, reinforcing that his work includes teaching and multidisciplinary discussion of how transplant teams make difficult, high-stakes selection decisions [4][10].
Education, Training, and Credentials
Columbia and NewYork-Presbyterian list Dr. Shenoy’s medical education at Chicago Medical School at Rosalind Franklin University, internship and residency at Boston University Medical Center, and fellowship at Brigham and Women’s Hospital. They also list board certification in Psychiatry and Psychosomatic Medicine [1][2].
Training pathway
References
- Columbia University Department of Psychiatry. Akhil Shenoy, MD. https://www.columbiapsychiatry.org/profile/akhil-shenoy-md
- NewYork-Presbyterian. Akhil Shenoy, MD at CUIMC/Presbyterian Hospital and Vanderbilt Clinic. https://doctors.nyp.org/akhil-shenoy-md/cuimc-presbyterian-hospital-and-vanderbilt-clinic
- NewYork-Presbyterian Black Liver Health Initiative. Our Team. https://www.nyp.org/blhi/team
- Columbia University Irving Medical Center, Department of Medical Humanities and Ethics. IPE Day 2023. https://www.mhe.cuimc.columbia.edu/interprofessional-education-ipe/ipe-day/ipe-day-2023
- Columbia University Department of Psychiatry. Consultation-Liaison Psychiatry Fellowship. https://www.columbiapsychiatry.org/education-and-training/clinical-fellowships/consultation-liaison-psychiatry-fellowship
- PubMed. Multimodal multidisciplinary management of alcohol use disorder in liver transplant candidates and recipients. https://pubmed.ncbi.nlm.nih.gov/35892051/
- PubMed. Scoring systems to assess relapse risk in alcohol use disorder presenting for early liver transplantation: A systematic review. https://pubmed.ncbi.nlm.nih.gov/34229280/
- PubMed. When Rejected Liver Transplant Candidates Seek a Second Center Opinion: Ethics at the Intersections of Medicine and Mores. https://pubmed.ncbi.nlm.nih.gov/37229743/
- PubMed. Multicenter investigation of the reliability and validity of the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT). https://pubmed.ncbi.nlm.nih.gov/30414243/
- Columbia University Irving Medical Center, Department of Medical Humanities and Ethics. IPE Day 2024. https://www.mhe.cuimc.columbia.edu/interprofessional-education-ipe/ipe-day/ipe-day-2024
